Stocks rise as inflation report keeps rate hikes on track


A pedestrian passes the New York Stock Exchange, Nov. 30, 2021, in New York. Stocks are opening higher, Wednesday, Jan. 12, 2022, after the latest report of surging prices appeared to keep the Federal Reserve on track to raise interest rates later this year. (AP Photo/John Minchillo, file)

Wall Street capped a day of wobbly trading with modest gains for stocks Wednesday, as investors weighed the implications of the latest economic snapshot showing rising inflation.

The S&P 500 rose 0.3% after veering between a loss of 0.1% and a gain of 0.8% over the course of the day. The Dow Jones Industrial Average eked out a 0.1% gain, while the Nasdaq composite rose 0.2%.

Investors were focused on a report from the Labor Department, which showed consumer prices jumped 7% last month. That's the fastest year-over-year pace in the consumer price index in nearly four decades. The sharp increase, which was in line with economists' forecasts, came a day after Fed Chair Jerome Powell told Congress that the central bank stands ready to raise rates to fight inflation.

“That's the next (thing) that investors are looking at, trying to figure out what the Fed is really, really going to do and what they really can do,” said Tom Martin, senior portfolio manager with Globalt Investments.

The S&P 500 index rose 13.28 points to 4,726.35. It's now about 1.5% below the all-time high it set early last week. The Dow gained 38.30 points to 36,290.32. The Nasdaq rose 34.94 points to 15,188.39. The indexes are all on pace for a weekly gain.

The modest gains were led by technology stocks, which have been choppy in recent days. The prospect of higher interest rates tends to make pricey sectors like tech less appealing. Microsoft rose 1% and chipmaker Nvidia rose 0.7%.

A mix of retailers and other companies that rely on direct consumer spending, such as auto companies, also made solid gains. Nike rose 1.3%.

Health care companies were the only laggard among stocks in the S&P 500. Biogen slid 6.7% on news that Medicare is limiting coverage of the biopharmaceutical company’s $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned.


Smaller company stocks lost ground. The Russell 2000 index fell 17.95 points, or 0.8%, to 2,176.06.

Bond yields were mostly stable. The yield on the 10-year Treasury fell to 1.73% from 1.74% late Tuesday.

Wall Street has been closely watching rising inflation to gauge the impact on businesses and consumers, as well as on the Fed's plan to trim its support for the economy and markets.

The central bank is reducing bond purchases that helped keep interest rates low throughout the virus pandemic. Investors are closely watching to see just how soon the Fed will start raising interest rates to fight inflation.

“We’re in a period where I don’t think we’ve ever been before with the amount of stimulus that was put to work,” said Greg Marcus, managing director of UBS Private Wealth Management. “You can't have that much of an increase without having inflation ticking up.”

The market now puts the chances of the Fed raising short-term rates by at least a quarter point in March at around 75%. A month ago, it was about 36%.

Wall Street will get another update on rising inflation on Thursday, when the Labor Department releases December results from an index based on U.S. wholesale prices, which shows how inflation is affecting costs for businesses.

Businesses in a wide range of industries have been passing higher costs off to consumers, but many have been warning that they will still feel a financial impact because of higher prices and supply chain problems. Medical products maker Cardinal Health was the latest to issue such a warning earlier this week.

Wall Street will be closely watching the latest round of earnings to see how companies are dealing with inflation. Several airlines and banks this week will be among the first big companies to report their latest financial results.

Delta Air Lines reports its results on Thursday. Citigroup, JPMorgan Chase and Wells Fargo report results on Friday.

Should you invest $1,000 in Cardinal Health right now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Cardinal Health (CAH)
4.3047 of 5 stars
$103.37+0.5%1.93%40.70Moderate Buy$103.07
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Search Headlines: